Hydroxysafflor yellow A (HSYA) targets the platelet-activating factor (PAF) receptor and inhibits human bronchial smooth muscle activation induced by PAF-Reference-Cited by-同舟云学术

Hydroxysafflor yellow A (HSYA) targets the platelet-activating factor (PAF) receptor and inhibits human bronchial smooth muscle activation induced by PAF

Published:2019 Issue:8 Volume:10 Page:4661-4673
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Guo Xinjing¹²³⁴⁵^ORCID,Zheng Meng¹²³⁴⁵,Pan Ruiyan¹²³⁴⁵,Zang Baoxia¹²³⁴⁵,Gao Jianwei¹²³⁴⁵,Ma Hanying⁶²³⁵⁷,Jin Ming¹²³⁴⁵

Affiliation:

1. Department of Pharmacology

2. Beijing Anzhen Hospital

3. Capital Medical University

4. Beijing Institute of Heart Lung and Blood Vessel Diseases

5. Beijing

6. Department of General practice

7. China

Abstract

HSYA suppressed the activation of human bronchial smooth muscle cells induced by platelet activating factor (PAF) in vitro by targeting the PAFR.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2019/FO/C9FO00896A

Reference53 articles.

1. Asthma pathogenesis, diagnosis, and management in the elderly

2. Neutrophilic inflammation in asthma: mechanisms and therapeutic considerations

3. Asthma and Allergic Inflammation

4. Eosinophil recruitment and activation: the role of lipid mediators

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Platelet Activating Factor as a Mediator of Inflammatory Diseases and Preterm Delivery;The American Journal of Pathology;2024-06

2. Highly oxidized rearranged derivatives of quinochalcone C-glycosides from Carthamus tinctorius;Phytochemistry;2024-06

3. HSYA prevents IL‐1β‐induced human chondrocyte damage in osteoarthritis by inhibiting NF‐κB activation;Chemical Biology & Drug Design;2024-02

4. Platelet‐activating factor as an endogenous cofactor of food anaphylaxis;BioFactors;2023-05-19

5. Mechanism of hydroxysafflor yellow A on acute liver injury based on transcriptomics;Frontiers in Pharmacology;2022-09-02